APA

Neveu C., Dulin F., Lefranc B., Galas L., Calbrix C., Bureau R., Rault S., Chuquet J., Boutin J. A., Guilhaudis L., Ségalas-Milazzo I., Vaudry D., Vaudry H., Santos J. S. O. & Leprince J. (20150609). Molecular basis of agonist docking in a human GPR103 homology model by site-directed mutagenesis and structure-activity relationship studies. : British journal of pharmacology.

Chicago

Neveu C, Dulin F, Lefranc B, Galas L, Calbrix C, Bureau R, Rault S, Chuquet J, Boutin J A, Guilhaudis L, Ségalas-Milazzo I, Vaudry D, Vaudry H, Santos J Sopkova-de Oliveira and Leprince J. 20150609. Molecular basis of agonist docking in a human GPR103 homology model by site-directed mutagenesis and structure-activity relationship studies. : British journal of pharmacology.

Harvard

Neveu C., Dulin F., Lefranc B., Galas L., Calbrix C., Bureau R., Rault S., Chuquet J., Boutin J. A., Guilhaudis L., Ségalas-Milazzo I., Vaudry D., Vaudry H., Santos J. S. O. and Leprince J. (20150609). Molecular basis of agonist docking in a human GPR103 homology model by site-directed mutagenesis and structure-activity relationship studies. : British journal of pharmacology.

MLA

Neveu C, Dulin F, Lefranc B, Galas L, Calbrix C, Bureau R, Rault S, Chuquet J, Boutin J A, Guilhaudis L, Ségalas-Milazzo I, Vaudry D, Vaudry H, Santos J Sopkova-de Oliveira and Leprince J. Molecular basis of agonist docking in a human GPR103 homology model by site-directed mutagenesis and structure-activity relationship studies. : British journal of pharmacology. 20150609.